Send to a Friend Share

UBS Starts Kemet (KEM) at Neutral; Restructuring Yields Benefits but Normalized Model Unclear

April 5, 2011 10:40 AM EDT
KEM Hot Sheet
Rating Summary:
    3 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 7 | New: 23
UBS initiates coverage on Kemet (NYSE: KEM) with a Neutral. PT $16.

UBS analyst says, "KEM is a manufacturer of capacitors and operates in three major segments – Tantalum, Ceramic, and Film and Electrolytic (F&E), with forecast FY11 (ending March 2011) sales of $1billion (up 36% Y/Y). Key end-markets include Auto, Telecom, Computing, and Indus trial/Lighting, with Bosch, Cisco (Nasdaq: CSCO), Continental, Dell (Nasdaq: DELL), HP (NYSE: HPQ), Motorola (NYSE: MOT), and Nokia (NYSE: NOK) among the leading OEM customers. With broad-based exposure, we foresee revenues growing at rates in line with industry CAGR of 5%."

"Our FY12 EPS estimate is $1.98, below the Street estimate of $2.26, primarily because we foresee the restocking tailwinds that benefited FY10 mitigating. However, at 7x EPS on our estimate, we believe the stock is already discounting downside risks. Further, any supply chain disruption from Japan could allow KEM to fulfill near-term demand."

For more ratings news on Kemet click here and for the rating history of Kemet click here.

Shares of Kemet closed at $15.04 yesterday, with a 52 week range of $2.06-$17.05.


Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In


Related Categories

New Coverage

Related Entities

UBS

Add Your Comment





Follow StreetInsider.com On Twitter